These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3277419)

  • 21. Low dose captopril twice daily lowers blood pressure without disturbance of the normal circadian rhythm.
    Meijer JL; Ardesch HG; van Rooijen JC; de Bruijn JH
    Postgrad Med J; 1986; 62 Suppl 1():101-5. PubMed ID: 3534845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A clinical study of the verapamil and captopril combination in hypertensive patients uncontrolled by monotherapy. An evaluation by recording the 24-hour ambulatory blood pressure].
    Mora-Macià J; Ocón Pujadas J; Fernández Vidal P; Garrido García J; Velasco Quintana J; del Río Pérez G
    Med Clin (Barc); 1993 Apr; 100(14):526-30. PubMed ID: 8469038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty-four-hour blood pressure monitoring and effects of indapamide.
    Ocon J; Mora J
    Am J Cardiol; 1990 May; 65(17):58H-61H. PubMed ID: 2330908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypertension and well-being: a study with indapamide].
    Rodrigues T; Macieira L; Alfaiate A; Gouveia-Oliveira A; Matias F; Corrêa-Nunes A; Carrageta MO
    Rev Port Cardiol; 1994 Jan; 13(1):21-8, 7. PubMed ID: 8155346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of the activity of a new agent, indapamide, in essential arterial hypertension.
    Hatt PY; Leblond JB
    Curr Med Res Opin; 1975; 3(3):138-44. PubMed ID: 1097194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once-daily treatment of essential hypertension with captopril.
    Schoenberger JA; Wilson DJ
    J Clin Hypertens; 1986 Dec; 2(4):379-87. PubMed ID: 3543231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
    Roca-Cusachs A; Oigman W; Lepe L; Cifkova R; Karpov YA; Harron DW
    Acta Cardiol; 1997; 52(6):495-506. PubMed ID: 9542575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
    London G; Schmieder R; Calvo C; Asmar R
    Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systemic hemodynamic evaluation of indapamide.
    Gensini G; Esente P; Giambartolomei A
    Clin Ther; 1983; 5(5):475-82. PubMed ID: 6616523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.
    Chalmers JP; Wing LM; Grygiel JJ; West MJ; Graham JR; Bune AJ
    Eur J Clin Pharmacol; 1982; 22(3):191-6. PubMed ID: 7049706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicentre open trial indapamide in general practice.
    Bowker CH; Murphy MA
    Postgrad Med J; 1981; 57 Suppl 2():53-6. PubMed ID: 7033948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studies.
    Mallion JM; Asmar R; Boutelant S; Guez D
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):673-8. PubMed ID: 9781939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
    Capone P; Vukovich RA; Neiss ES; Bolton S; Reeves RL
    Clin Ther; 1983; 5(3):305-16. PubMed ID: 6342786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once daily lisinopril and captopril in hypertension: a double blind comparison using ambulatory monitoring.
    Mann S; O'Brien KP
    N Z Med J; 1994 Oct; 107(987):391-4. PubMed ID: 7936476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability and well-being with indapamide in the treatment of mild-moderate hypertension. An Italian multicenter study.
    Leonetti G; Rappelli A; Salvetti A; Scapellato L
    Am J Med; 1988 Jan; 84(1B):59-64. PubMed ID: 3277420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker.
    Yamada H; Mishiro Y; Kusunose K; Sata M
    J Cardiovasc Pharmacol Ther; 2010 Jun; 15(2):145-50. PubMed ID: 20200326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversions from captopril to lisinopril at a dosage ratio of 5:1 result in comparable control of hypertension.
    Gill TH; Hauter F; Pelter MA
    Ann Pharmacother; 1996 Jan; 30(1):7-11. PubMed ID: 8773158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide.
    Plante GE; Dessurault DL
    Am J Med; 1988 Jan; 84(1B):98-103. PubMed ID: 3341391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative trial of indapamide and hydrochlorothiazide in essential hypertension, with forearm plethysmography.
    Kreeft JH; Langlois S; Ogilvie RI
    J Cardiovasc Pharmacol; 1984; 6(4):622-6. PubMed ID: 6206316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the effect-duration of once-daily enalapril compared with once-daily captopril.
    Germanò G; Damiani S; Germanò U; Pecchioli V; Pica B; Antonini P
    Nephron; 1990; 55 Suppl 1():65-9. PubMed ID: 2189075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.